COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 2317: Articles 23161-23170  | Next

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Walsh, E. E., Frenck, R., Falsey, A. R., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Mulligan, M. J., Bailey, R., Swanson, K. A., Li, P., Koury, K., Kalina, W., Cooper, D., Fontes-Garfias, C., Shi, P.-Y., Türeci, O., Thompkins, K. R., Lyke, K. E., Raabe, V., Dormitzer, P. R., Jansen, K. U., Sahin, U., Gruber, W. C.
10.1101/2020.08.17.20176651 — Posted: 2020-08-20
Identification of potential key genes for SARS-CoV-2 infected human bronchial organoids based on bioinformatics analysis
Gu, H., Yuan, G.
10.1101/2020.08.18.256735 — Posted: 2020-08-19
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Guebre-Xabier, M., Patel, N., Tian, J.-H., Zhou, B., Maciejewski, S., Lam, K., Portnoff, A. D., Massare, M. J., Frieman, M. B., Piedra, P. A., Ellingsworth, L. R., Glenn, G., Smith, G.
10.1101/2020.08.18.256578 — Posted: 2020-08-19
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells
Dominguez Andres, A., Feng, Y., Campos, A. R., Yin, J., Yang, C.-C., James, B., Murad, R., Kim, H., Deshpande, A. J., Gordon, D. E., Krogan, N. J., Pippa, R., Ronai, Z. A.
10.1101/2020.08.18.256776 — Posted: 2020-08-19 Discussion: Onsite | Offsite
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques
Ishigaki, H., Nakayama, M., Kitagawa, Y., Nguyen, C. T., Hayashi, K., Shiohara, M., Gotoh, B., Itoh, Y.
10.1101/2020.08.18.256446 — Posted: 2020-08-19
Information given by websites selling home self-sampling COVID-19 tests: An analysis of accuracy and completeness
Taylor-Phillips, S., Berhane, S., Sitch, A., Freeman, K., Price, M., Davenport, C., Geppert, J., Harris, I., Osokogu, O., Skrybant, M., Deeks, J. J.
10.1101/2020.08.18.20177360 — Posted: 2020-08-19
Suboptimal SARS-CoV-2-specific CD8+ T-cell response associated with the prominent HLA-A*02:01 phenotype
Habel, J. R., Nguyen, T. H. O., van de Sandt, C. E., Juno, J. A., Chaurasia, P., Wragg, K., Koutsakos, M., Hensen, L., Chua, B., Zhang, W., Tan, H. X., Flanagan, K. L., Doolan, D., Torresi, J., Chen, W., Wakim, L., Cheng, A., Petersen, J., Rossjohn, J., Wheatley, A. K., Kent, S., Rowntree, L., Kedzierska, K.
10.1101/2020.08.17.20176370 — Posted: 2020-08-19 Discussion: Onsite | Offsite
Knowledge and Perception of COVID-19, Prevalence of Pre-Existing Conditions, and Access to Essential Resources and Health Services in Somali IDP Camps
Alawa, J., Walz, L. A., Al-Ali, S., Wiles, E., Harle, N., Abdullahi, A. M., Mohamed, D., Khoshnood, K.
10.1101/2020.08.17.20176271 — Posted: 2020-08-19
SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology.
Molteni, E., Astley, C. M., Ma, W., Sudre, C. H., Magee, L. A., Murray, B., Fall, T., Gomez, M. F., Tsereteli, N., Franks, P. W., Brownstein, J. S., Davies, R., Wolf, J., Spector, T., Ourselin, S., Steves, C., Chan, A. T., Modat, M.
10.1101/2020.08.17.20161760 — Posted: 2020-08-19
The necessary cooperation between governments and public in the fight against COVID-19: why non-pharmaceutical interventions may be ineffective
Borges, C. M., Coelho, M. T. P., Diniz-Filho, J. A. F., Rangel, T. F.
10.1101/2020.08.17.20176347 — Posted: 2020-08-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).